Tillis Calls on DEA to Remove Barriers to Lifesaving Opioid Use Disorder Treatment
May 17, 2023
May 17, 2023
WASHINGTON, May 17 -- Sen. Thom Tillis, R-North Carolina, issued the following news release and letter:
U.S. Senator Thom Tillis (R-NC) and a bipartisan group of senators are calling on the Drug Enforcement Administration (DEA) to take further action to remove barriers to buprenorphine, a lifesaving drug used to treat opioid use disorder.
Specifically, the senators are urging the DEA to initiate a multi-agency evaluation of buprenorphine with the Food and Drug Administr . . .
U.S. Senator Thom Tillis (R-NC) and a bipartisan group of senators are calling on the Drug Enforcement Administration (DEA) to take further action to remove barriers to buprenorphine, a lifesaving drug used to treat opioid use disorder.
Specifically, the senators are urging the DEA to initiate a multi-agency evaluation of buprenorphine with the Food and Drug Administr . . .